| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S2214-109X(20)30119-4 |
| P698 | PubMed publication ID | 32562650 |
| P50 | author | M. Maria Glymour | Q85357387 |
| P2093 | author name string | Grant Dorsey | |
| Moses R Kamya | |||
| Roly Gosling | |||
| R Matthew Chico | |||
| Stephen Shiboski | |||
| Abel Kakuru | |||
| Meghna Desai | |||
| Julie Gutman | |||
| Michelle E Roh | |||
| Feiko O Ter Kuile | |||
| Francois Rerolle | |||
| Richard Kajubi | |||
| Anne L'Ianziva | |||
| P2860 | cites work | Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis | Q26795623 |
| Identifiability and exchangeability for direct and indirect effects | Q28239361 | ||
| Identification, Inference and Sensitivity Analysis for Causal Mediation Effects | Q29299994 | ||
| Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections | Q33589254 | ||
| The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. | Q34292898 | ||
| Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin | Q34322250 | ||
| Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa | Q35920636 | ||
| Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. | Q36141555 | ||
| Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op | Q36478633 | ||
| Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight | Q36603993 | ||
| Malaria in pregnancy: pathogenesis and immunity | Q36717621 | ||
| Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy | Q36843561 | ||
| Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review | Q37848714 | ||
| Efficacy of treatment regimens for lower urogenital Chlamydia trachomatis infection in women | Q37908373 | ||
| Mediation Analysis: A Practitioner's Guide | Q38665039 | ||
| Dosage of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in a Cohort of Zambian Pregnant Women in a Low Malaria Prevalence Region | Q39229580 | ||
| Placental Malaria: A New Insight into the Pathophysiology | Q40100988 | ||
| Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda | Q41992238 | ||
| Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More Than Just an Antimalarial? | Q42330176 | ||
| Introduction of Sulfonamide Therapy for Gonorrhea | Q70311298 | ||
| Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial | Q92610098 | ||
| Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis | Q92684763 | ||
| P433 | issue | 7 | |
| P304 | page(s) | e942-e953 | |
| P577 | publication date | 2020-07-01 | |
| P1433 | published in | The Lancet Global Health | Q27667673 |
| P1476 | title | Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis | |
| P478 | volume | 8 |
| Q96613062 | Defining the combined benefit of intermittent preventive malaria treatment in pregnancy | cites work | P2860 |
Search more.